Cargando…
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show t...
Autores principales: | Jessen, Christina, Kreß, Julia K. C., Baluapuri, Apoorva, Hufnagel, Anita, Schmitz, Werner, Kneitz, Susanne, Roth, Sabine, Marquardt, André, Appenzeller, Silke, Ade, Carsten P., Glutsch, Valerie, Wobser, Marion, Friedmann-Angeli, José Pedro, Mosteo, Laura, Goding, Colin R., Schilling, Bastian, Geissinger, Eva, Wolf, Elmar, Meierjohann, Svenja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605435/ https://www.ncbi.nlm.nih.gov/pubmed/32978520 http://dx.doi.org/10.1038/s41388-020-01477-8 |
Ejemplares similares
-
NRF2 Enables EGFR Signaling in Melanoma Cells
por: Kreß, Julia Katharina Charlotte, et al.
Publicado: (2021) -
PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022) -
Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients
por: Wobser, Marion, et al.
Publicado: (2021) -
Panel Sequencing of Primary Cutaneous B-Cell Lymphoma
por: Wobser, Marion, et al.
Publicado: (2022) -
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
por: Grimm, Johannes, et al.
Publicado: (2018)